血管内覆膜支架行颈动脉重建:避免颈动脉血流中断的创新策略
本研究报道了一种基于血管内覆膜支架的颈动脉重建术(CAR-ECS),用于治疗累及颈动脉的头颈癌(HNC-CA)。2019年6月至2020年12月共18例患者接受该手术,均成功完成支架植入、肿瘤切除和颈动脉重建,无颈动脉破裂综合征、神经功能障碍或围手术期死亡。肿瘤侵犯所致狭窄血管内径从5.40 ± 1.31 mm增至7.32 ± 0.68 mm(p < 0.05)。平均随访11.7个月(范围5-22个月),1年总生存率为61.31%,中位生存时间15.0个月(95% CI:7.6-22.4),局部区域复发率33.3%,远处转移率22.2%。
要点
- CAR-ECS技术无需术中中断颈动脉血流,避免了血管吻合操作。
- 18例HNC-CA患者均成功完成手术,无颈动脉破裂综合征、神经功能障碍或围手术期死亡。
- 狭窄血管内径从5.40 ± 1.31 mm增至7.32 ± 0.68 mm(p < 0.05)。
核心结论
- 作者提出一种新型颈动脉重建术(CAR-ECS),并证明其在降低手术风险、保障患者预后方面安全可靠。
研究设计与样本
- 本研究为病例系列,2019年6月至2020年12月共纳入18例累及颈动脉的头颈癌(HNC-CA)患者接受CAR-ECS手术。
主要发现
- 血管内覆膜支架植入(ECSI)、肿瘤切除和颈动脉重建均成功完成。
- 无颈动脉破裂综合征、神经功能障碍或围手术期死亡病例。
- 肿瘤侵犯所致狭窄血管内径从5.40 ± 1.31 mm增至7.32 ± 0.68 mm(p < 0.05)。
- 平均随访11.7个月(范围5-22个月),1年总生存率为61.31%,中位生存时间15.0个月(95% CI:7.6-22.4)。
- 局部区域复发率为33.3%,远处转移率为22.2%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid artery reconstruction is the preferred approach for treating head and neck cancer involving carotid artery (HNC-CA). While current techniques often utilize various autologous or synthetic materials for reconstruction, they pose risks such as intraoperative carotid blood flow interruption and postoperative anastomotic thrombosis. Here, we report a carotid artery reconstruction based on endovascular covered stent (CAR-ECS), which uses an endovascular covered stent implantation (ECSI) technique that does not require intraoperative interruption of carotid blood flow and avoids vascular anastomotic maneuvers. METHODS: Between June 2019 and December 2020, 18 patients with HNC-CA underwent the CAR-ECS surgery. RESULTS: ECSI, tumor resection, and carotid artery reconstruction were successfully performed. There were no cases of carotid blowout syndrome, neurologic dysfunction, or perioperative death. Stenotic vessel internal diameter due to tumor invasion increased from 5.40 ± 1.31 mm to 7.32 ± 0.68 mm (p < 0.05). During a mean follow-up period of 11.7 months (range: 5-22 months), the 1-year overall survival rate was 61.31%, with a median survival time of 15.0 months (95% CI: 7.6-22.4). The locoregional recurrence rate was 33.3%, and the distant metastasis rate was 22.2%. CONCLUSIONS: In this study, we propose a novel carotid artery reconstruction and demonstrate the safety and reliability of CAR-ECS in reducing surgical risk and safeguarding patient prognosis.
引用
- Sun K, Wang C, Gong S, et al. Carotid Artery Reconstruction With Endovascular Covered Stents: An Innovative Strategy to Avoid Interruption of Carotid Blood Flow. Head Neck. 2025. PMID: 40344304. doi:10.1002/hed.28188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。